Chondroitin Research Paper

Joint pain, particularly in the knees and shoulders as well as back pain constitute the large majority of patients who present to their doctor's office with a complaint of pain. Many of these patients proceed to have surgery, all too often with less than optimal outcomes. Many of these patients still have the same pain

The type of treatment chosen depends on the type of arthritis and the effects it has on the patient as well as the severity of the disease. Other factors to consider are the age of the patient and the joints affected. Bearing in mind that different people exhibit different reactions to different medications, treatment in this case is individualized but includes a combination of joint protection methods and medication. For rheumatoid arthritis, the Initial treatment starts with non steroidal ant inflammatory drugs and other simple analgesic but as the inflammation progresses, slow acting anti rheumatoid drugs which are aimed at modifying the disease are introduced. They are added progressively as the inflammation progresses in order to suppress the process that leads to chronic inflammation (Amin 1995).

Osteoarthritis, or degenerative joint disease, is a form of arthritis characterized by the breakdown of cartilage within joints. Cartilage serves to provide cushion at the ends of bones, and when the cushion is not sufficient, as in osteoarthritis, the bones rub together. As a result, osteoarthritis sufferers are constantly plagued by stiff, swollen, and inflamed joints (http://www.arthritis.org/answers/diseasecenter/oa.asp). It is a relatively common condition, with an estimated 20 million American sufferers, most of whom are elderly (http://webmd.lycos.com/content/article/1668.50297). Traditional treatments include Tylenol, aspirin, or other non-steroidal anti-inflammatory drugs

Chondroitin: This substance occurs naturally in the connective tissues. Chondroitin supplements are effective at helping treat osteoarthritis,

Non-steroidal anti-inflammatory drugs (NSAIDs) are the foundation of medical treatment for osteoarthritis (OA). It is the most common medication taken by an individual experiencing pain due to this degenerative joint disease. Not to mention, NSAIDS are prescribed for pain management in older adults since they are more efficacious than acetaminophen with the absence of central nervous system side effects of opioids

Osteoarthritis, the most common type of arthritis, is most prevalent in older patients. Osteoarthritis is a degenerative bone disease due to the gradual loss of cartilage. A primary type of osteoarthritis is hip arthritis where it is caused by joint injury, increasing age, and being overweight (“Hip Osteoarthritis,” n.d.). However, osteoarthritis can also be caused by immature joints, inherited defects in cartilage, and extra stress on a patient’s joints (Hip Osteoarthritis,” n.d.). As a result, hip arthritis becomes a huge detriment in patient’s social, emotional, physical lifestyles. In order to treat hip arthritis, doctors choose from a variety of non-drug treatments, medications, and surgeries. Uniquely, I was inspired to research about the treatments of hip arthritis because my very own brother was pronounced with hip arthritis a few years back. Therefore, his determination to battle this disease encouraged me to investigate about the treatment of hip arthritis.

It has also been shown that the pain relief is very similar or even the same as that experienced by patients taking NSAIDs (nonsteroidal anti-inflammatory medications). The benefit of liquid glucosamine chondroitin over NSAIDs is the lack of side effects and discomfort.

It is found in your skin, muscles, bones, tendons and many other places. As we age, our body’s collagen production start to decrease and this will start to be noticed physically through the appearance of wrinkles or joint pain as collagen is the “glue” that holds joint together. Collagen can be found in the form of a nutritional supplement and is made from protein. If you suffer from joint pain, collagen supplementation can be of a big help. It will help improve your pain by stimulating your body to produce more joint collagen as it is rich in amino acids, one of the basic building blocks of the human body, thus having a structural function. Our enhanced Collagen by Organika is hydrolyzed for easy absorption and will also improve the health of your hair, nail and

In only severe case do extreme symptoms present which are very rare. There is no complete cure to any of the condition however using Meloxicam can decrease pain as well as lessen the symptoms. Meloxicam is used to treat both of these conditions for an extended period of time, but osteoarthritis is treated (with Meloxicam) only on a short term bases. Osteoarthritis is a condition which almost everyone will eventually suffer from. Currently 8/10 people aged over 50 suffer, every joint can be effected as the cause of osteoarthritis is the extended use of the joints which causes the cartilage to become thin and uneven. The synovial fluid also becomes thicker and excess is also produced which cause the joint swell, bony spurs can also grow which also lead to further inflammation in the surrounding tissue. All of the conditions mentioned above have one similarity in that they all cause an inflammatory response. Meloxicam inhibits the production of prostaglandins which are the chemical messengers which stimulate an immune response and results in inflammation. It specifically inhibits the cyclo-oxygenase process which is the process in which prostaglandins are produced.

The following are some of the best smoothy that helps to prevent chronic knee and joint pain

Curcumin is a very active compound and is responsible for the yellow color of turmeric which has antioxidant and anti-inflammatory properties that can have a significant effect on osteoarthritis by the protection of chondrocytes. The aim of this study was to evaluate the effectiveness of curcumin in reducing the symptoms of patients with osteoarthritis of the knee. In this interventional study, curcumin and placebo will be prescribed to the groups and a random number table will be used for treatment allocation by the statistical analyzer. Patients and researchers will not know the group of the patients and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) will be completed for patients in 0 and 6 weeks of drug using. In this study, WOMAC questionnaire will be completed for 80 patients (40 patients in curcumin group and 40 patients in the placebo group) with knee osteoarthritis in 0 and 6

Osteoarthritis is the most common joint disorder, and more than half of all Americans who are older than 65 have been diagnosed with osteoarthritis. However, recent US data has revealed knee osteoarthritis does not discriminate age, and there is growing evidence that osteoarthritis affects individuals at a young age. The annual cost of osteoarthritis due to treatment and loss of productivity in the US is estimated to be more than 65 billion dollars.1 With no cure currently available for osteoarthritis, current treatments focus on management of symptoms. The primary goals of therapy include improved joint function, pain relief, and increased joint stability. Although the exact cause of osteoarthritis is unknown, many risk factors have been identified including increased age, female gender, obesity, and trauma.2 Within these risk factors, the etiology of osteoarthritis has been divided into anatomy, body mass, and gender.

This essay is aimed to critically appraise the article about “comparing the effect of glucosamine and glucosamine with alendronate in symptomatic relieve of degenerative knee joint disease” (Hamid Reza Arti & Mohammad Ebrahim Azemi, 2012, p. 87-92). The study talked about the Degenerative Joint Disease (DJD) or osteoarthritis, which is the most common destructive joint disease and causes of chronic disability in human beings. Osteoarthritis is often caused by aging, frequent use of knee joints or obesity. People with osteoarthritis are normally treated by glucosamine. On the other hand, alendronate is used to treat osteoporosis. People with osteoporosis will have brittle or fragile bones due to deficiency in calcium or vitamin D. As both osteoarthritis and osteoporosis have higher chances of being found in elderly patients, it might not be an unusual thing for them to exist together in the patient at the same time. Combining glucosamine and alendronate together in the treatment may bring out unexpected therapeutic benefits. The objective of the study is to find out the differences between the effects of glucosamine alone and combination between glucosamine and alendronate administration in relieving knee degeneration. The study hypothesised that combination of glucosamine and alendronate will be more effective in treating knee degeneration.

Glucosamine is one of the biological components that helps to create more support for the joints and helps to exert a protective effect against joint destruction in conditions associated with osteoarthritis. In healthy glucosamine is produced in the body naturally. Because one of the ingredients of glucosamine is glucose, a naturally occurring sugar classified as an amino sugar. However, glucosamine does not behave in the body as an energy source. Instead, it serves to blend sulphur into the cartilage and other body tissues. It is involved to maintain and repair the bones, joints, cartilage & in the treatment of degenerative joint diseases (Chiusaroli et al., 2011; Distler and Anguelouch, 2006; Rangle and Sawitzke, 2012). Glucosamine is also involved in constructing nails, skin, eyes, bones, ligaments, tendons, heart valves, discharging mucous from the respiratory system, digestive system, and urinary tract.

In the United States, arthritis has become the second most common disorder, in the past years. Moreover, the condition affects more than 34 million Caucasians, 4.6 million African-Americans and nearly 3.1 million Hispanics with women being the most affected (Helmick, 2008). 28.3% of people suffering from arthritis are women whereas 18.2% are men (Helmick, 2008). By the year 2030, it is predicted that the number of patients with arthritis will double if prevalence rates remain the same. Apart from being cost-intensive, Osteoarthritis (OA) affects nearly twenty seven million Americans, which effectively limits their work (Reid, Shengelia & Parker, 2012). The statistics show that Caucasians are the most affected and the Hispanics to be the less affected from Caucasians, Hispanics, and African Americans. It also shows how women also have greater possibilities of getting arthritis than man ever did.